1. Home
  2. ROCK vs ABCL Comparison

ROCK vs ABCL Comparison

Compare ROCK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

N/A

Current Price

$37.45

Market Cap

1.2B

Sector

N/A

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$5.34

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROCK
ABCL
Founded
1972
2012
Country
United States
Canada
Employees
2221
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
ROCK
ABCL
Price
$37.45
$5.34
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$8.40
AVG Volume (30 Days)
326.8K
8.5M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$1,135,501,000.00
$75,128,000.00
Revenue This Year
$41.26
N/A
Revenue Next Year
$20.14
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$33.56
$1.98
52 Week High
$75.08
$6.52

Technical Indicators

Market Signals
Indicator
ROCK
ABCL
Relative Strength Index (RSI) 50.92 63.20
Support Level $37.77 $3.45
Resistance Level $40.84 $5.63
Average True Range (ATR) 1.73 0.41
MACD 0.16 0.04
Stochastic Oscillator 62.64 74.56

Price Performance

Historical Comparison
ROCK
ABCL

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewable Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: